Skip to main content

Table 2 Proportion of RSV hospitalizations by diagnosis and observation period

From: Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis

   Total Compliant Non-compliant p-value
   (N = 5,003) (N = 1,912) (N = 3,091)  
Post-index Period
RSV hospitalization n 57 7 50  
  % 1.14 0.37 1.62 <0.001
RSV-like hospitalization n 119 33 86  
  % 2.38 1.73 2.78 0.017
Full RSV Season
RSV hospitalization n 88 9 79  
  % 1.76 0.47 2.56 <0.001
RSV-like hospitalization n 154 38 116  
  % 3.08 1.99 3.75 <0.001